FDA Adverse Event Injury Summary report: N

VERSAFITCUP CC TRIO NO-HOLE ACETABULAR SHELL Ø 54

MDR report key: 6331854 · Received February 15, 2017

Report

Report Number
3005180920-2017-00038
Event Type
Injury
Date Received
February 15, 2017
Report Date
February 15, 2017
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
PMA / PMN Number
K122911
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT HAS HAD PAIN FOR MONTHS. AT FIRST, A REVISION SURGERY HAS BEEN PLANNED DUE TO PROBABLE STEM LOOSENING. ADDITIONAL INFORMATION RECEIVED FROM THE INITIAL REPORTER ON (B)(6) 2017 AND INCLUDES: THE SURGEON SUSPECTED CUP MALPOSITIONING DURING PRIMARY SURGERY BY HIMSELF INSTEAD OF STEM LOOSENING. THE EVENT WILL BE CONFIRMED AT REVISION. ADDITIONAL INFORMATION RECEIVED FROM THE INITIAL REPORTER ON (B)(6) 2017 AND INCLUDES: THE REVISION WAS DONE ON (B)(6) 2017. ADDITIONAL INFORMATION RECEIVED FROM THE INITIAL REPORTER ON 14 FEBRUARY 2017 AND INCLUDES: THE STEM AND THE CUP WERE NOT LOOSE. THE STEM WAS REVISED DUE TO PAIN AND THE CUP WAS REVISED DUE TO MALPOSITIONING IN PRIMARY. BATCH REVIEW PERFORMED ON 14 FEBRUARY 2017. LOT 150143: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 12 MAY 2015. EXPIRATION DATE: 2020-03-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. BATCH REVIEW PERFORMED ON 15 FEBRUARY 2017. LOT 154182: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 21 OCTOBER 2015. EXPIRATION DATE: 2020-04-10. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY SIMILAR REPORTED EVENT. DEVICE NOT AVAILABLE.

Description of Event or Problem · 1

STEM REVISION DUE TO PAIN AND CUP REVISION DUE TO MALPOSITIONING IN PRIMARY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
113673 VERSAFITCUP CC TRIO NO-HOLE ACETABULAR SHELL Ø 54 ACETABULAR SHELL LZO MEDACTA INTERNATIONAL SA 154182

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention